Ethical challenges posed by zidovudine treatment to reduce vertical transmission of HIV

R Bayer

Editorial

R Bayer. N Engl J Med. 1994.

. 1994 Nov 3;331(18):1223-5.

doi: 10.1056/NEJM199411033311811.

R Bayer

Erratum in

No abstract available

Ethical issues in the use of zidovudine to reduce vertical transmission of HIV.
Hoffman CA, Munson R. Hoffman CA, et al. N Engl J Med. 1995 Mar 30;332(13):891-2. doi: 10.1056/NEJM199503303321314. N Engl J Med. 1995. PMID: 7870152 No abstract available.
Ethical issues in the use of zidovudine to reduce vertical transmission of HIV.
De Roo A, Colebunders R. De Roo A, et al. N Engl J Med. 1995 Mar 30;332(13):892. N Engl J Med. 1995. PMID: 7870153 No abstract available.
Ethical issues in the use of zidovudine to reduce vertical transmission of HIV.
Thea DM. Thea DM. N Engl J Med. 1995 Mar 30;332(13):892. N Engl J Med. 1995. PMID: 7870154 No abstract available.

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al. Connor EM, et al. N Engl J Med. 1994 Nov 3;331(18):1173-80. doi: 10.1056/NEJM199411033311801. N Engl J Med. 1994. PMID: 7935654 Clinical Trial.